Zdrowie i gospodarka · 13/04/2006
FDA Releases Guidance on Immunotoxicity Studies for Human Pharmaceuticals
The FDA has made available a guidance document outlining recommendations for nonclinical testing to identify immunotoxic compounds in human pharmaceuticals, developed in collaboration with the International Conference on Harmonisation.
Source: Federal Register — Food and Drug AdministrationOpen original release →